Henan Lingrui Pharmaceutical Co Ltd banner

Henan Lingrui Pharmaceutical Co Ltd
SSE:600285

Watchlist Manager
Henan Lingrui Pharmaceutical Co Ltd Logo
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Watchlist
Price: 21.45 CNY -0.65% Market Closed
Market Cap: ¥12.2B

Henan Lingrui Pharmaceutical Co Ltd
Income from Continuing Operations

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Henan Lingrui Pharmaceutical Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Income from Continuing Operations
¥802.2m
CAGR 3-Years
22%
CAGR 5-Years
22%
CAGR 10-Years
21%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Income from Continuing Operations
¥5.6B
CAGR 3-Years
29%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Income from Continuing Operations
¥8.1B
CAGR 3-Years
28%
CAGR 5-Years
5%
CAGR 10-Years
13%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Income from Continuing Operations
¥5.2B
CAGR 3-Years
22%
CAGR 5-Years
-1%
CAGR 10-Years
7%
Zhejiang Nhu Co Ltd
SZSE:002001
Income from Continuing Operations
¥6.8B
CAGR 3-Years
23%
CAGR 5-Years
14%
CAGR 10-Years
33%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Income from Continuing Operations
¥3.7B
CAGR 3-Years
N/A
CAGR 5-Years
244%
CAGR 10-Years
N/A
No Stocks Found

Henan Lingrui Pharmaceutical Co Ltd
Glance View

Market Cap
12.2B CNY
Industry
Pharmaceuticals

Nestled in the heart of China's Henan province, Henan Lingrui Pharmaceutical Co Ltd has quietly crafted a legacy in the pharmaceutical sector, blending traditional Chinese medicine with modern medical practices. Founded in an environment rich in natural resources, the company takes pride in its extensive portfolio that includes a broad range of pharmaceutical products such as tablets, injections, ointments, and Chinese patent medicines. The company's approach is an intricate dance between ancient wisdom and contemporary science, where herbal remedies are often synthesized with cutting-edge pharmaceutical manufacturing processes. Priding itself on research and development, Lingrui regularly collaborates with esteemed medical institutions, ensuring that its offerings remain both innovative and deeply rooted in traditional therapeutic principles. The financial heartbeat of Henan Lingrui is sustained through a strategic balance of domestic sales and international exports, capitalizing on the rising global demand for natural and alternative medicines. As the company expands its footprint, it continues to harness its robust supply chain and distribution channels to seamlessly deliver its products to hospitals, pharmacies, and health institutions across various regions. Indeed, the harmonious blend of traditional and modern methodologies not only defines Lingrui's operations but also shapes its revenue streams. By adhering to stringent quality standards and fostering partnerships, Henan Lingrui Pharmaceutical not only thrives in its local market but also competes in diverse international arenas, leveraging its unique product offerings as a cornerstone for financial growth.

Intrinsic Value
25.11 CNY
Undervaluation 15%
Intrinsic Value
Price ¥21.45

See Also

What is Henan Lingrui Pharmaceutical Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
802.2m CNY

Based on the financial report for Sep 30, 2025, Henan Lingrui Pharmaceutical Co Ltd's Income from Continuing Operations amounts to 802.2m CNY.

What is Henan Lingrui Pharmaceutical Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
21%

Over the last year, the Income from Continuing Operations growth was 19%. The average annual Income from Continuing Operations growth rates for Henan Lingrui Pharmaceutical Co Ltd have been 22% over the past three years , 22% over the past five years , and 21% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett